Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
ABBVIE LIMITED,Venetoclax (w current access azacitidine or low dose cytarabine),"AML, newly diagnosed,  ineligible for intensive chemotherapy",Venetoclax (w current access azacitidine or low dose cytarabine) (Venclexta),,Community and Hospital,Oncology Agents and Immunosuppressants
